Recovery from chronic fatigue syndrome with modafinil

Human Psychopharmacology

Volumn 19, Issue 1, 2004, Pages 63-64

  Turkington, Douglas ^a   Hedwat, Daniel ^a   Rider, Iain ^a   Young, Allan H ^a,b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; FLUOXETINE; MODAFINIL; TEMAZEPAM; ZOPICLONE;

ACUTE DISEASE; ADULT; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; CONVALESCENCE; COXSACKIE VIRUS INFECTION; DISEASE COURSE; GENERAL CONDITION DETERIORATION; HUMAN; MALAISE; MALE; MYALGIA; PAIN; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; REMISSION; SLEEP DISORDER; SYMPTOMATOLOGY; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; TREATMENT OUTCOME;

EID: 0742289911     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.554     Document Type: Article

References (10)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. 1994. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121: 953-959.
2. Ferraro L, Antonelli T, Tanganelli S, et al. 1999. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABA-A receptor blockade. Neuropsychopharmacology 20: 346-356.
3. Happe S, Pirker W, Sauter C, Klosch G, Zeitlhofer J. 2001. Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil. J Neurol 248: 632-634.
4. Lechin F, van der Dijs B, Pardey-Maldonado B, et al. 2000. Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients. J Med 31: 333-361.
5. Parker AJ, Wessely S, Cleare AJ. 2001. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 31: 1331-1345.
6. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. 2002. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 72: 179-183.
7. Stone EA, Cotecchia S, Liu Y, Quartermain D. 2002. Role of brain alpha 1β-adrenoceptors in modafinil-induced behavioural activity. Synapse 46: 269-270.
8. US Modafinil in Narcolepsy Multicenter Study Group. 2000. Randomised trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 54: 1166-1175.
9. Wearden AJ, Morriss RK, Mullis R, et al. 1998. Randomised, double-blind, placebo-controlled treatment of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 172: 485-490.
10. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. 2001. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 286: 1360-1368.